Testicular vein thrombosis: Incidence of recurrent venous thromboembolism and survival. Eur J Haematol 2018 Jan;100(1):83-87
Date
11/14/2017Pubmed ID
29131406DOI
10.1111/ejh.12985Scopus ID
2-s2.0-85038602249 (requires institutional sign-in at Scopus site) 9 CitationsAbstract
PURPOSE: Testicular vein thrombosis (TVT) etiology, recurrence, and survival were compared with lower extremity deep vein thrombosis (DVT) in order to determine whether treatment guidelines for DVT could be applied to TVT.
PATIENTS AND METHODS: An inception cohort of patients with confirmed TVT (January 1995-October 2015) was compared to a control group of patients with lower extremity DVT matched by age, gender, and diagnosis date.
RESULTS: Thirty-nine men with TVT were identified; 15 (38%) with isolated TVT. Left testicular vein was affected in 77% patients; there were no cases of bilateral TVT. Cancer was over twofold more common in TVT patients (59% vs 28%, P = .01). Most cancers (78%) involved organs in proximity to the testicular vein. Although TVT patients were less frequently treated with anticoagulants (49% vs 97%, P = .0001), recurrence rates were similar to DVT group (TVT 4.2 vs DVT 1.1 per 100 patient-years, P = .11). Despite higher cancer prevalence, survival rates were similar between groups (31% vs 28%; P = .34). Major bleeding events were rare (one patient per group).
CONCLUSIONS: Identifying TVT should prompt a search for a regional malignancy. Despite the high cancer prevalence and low utilization of anticoagulants, recurrent venous thrombosis and mortality rates are similar to DVT patients.
Author List
Lenz CJ, McBane RD, Cohoon KP, Janczak DT, Simmons BS, Saadiq RA, Mimier M, Casanegra AI, Daniels PR, Wysokinski WEAuthor
Kevin Cohoon DO Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAged
Comorbidity
Humans
Incidence
Male
Middle Aged
Prevalence
Recurrence
Risk Factors
Survival Rate
Testicular Diseases
Venous Thromboembolism
